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Introduction
The introduction of breast screening programmes led to
wider employment of minimally invasive diagnostic
methods. Fine needle aspiration (FNA) and core biopsy
are now universally accepted as methods that virtually
eliminate the need for open biopsy or frozen sections in
diagnosis of breast cancer. However, rapid growth in the
use of these methods presents the pathologist with
certain challenges relating to the reduced size of material
obtained, in combination with the wide variety of breast
lesions that may be identified. This article summarizes the
major diagnostic issues related to these techniques.
Fine needle aspiration cytology
Aspiration cytology has been practised for more than
50 years [1]. It was initially introduced to replace incisional
biopsy, which is an invasive method. Over this period the
technique has been used extensively for the diagnosis of
breast lesions, and it forms an integral part of the triple
approach to management of breast cancer. Although the
technique is well suited to the superficial nature of breast
lesions, and is highly sensitive and specific in their diagnosis,
like any other techniques it has limitations that can lead to
false-negative and false-positive results. Nevertheless, its role
in the diagnosis of breast lesions cannot be underestimated.
Cystic lesions
Use of FNA in the evaluation of cystic lesions can be both
diagnostic and therapeutic. Complete aspiration of cyst
contents can result in collapse of the cyst and stripping of
the lining epithelium. Cytological findings are variable.
Some fluids are acellular whereas others contain foam
cells, inflammatory cells, benign epithelium and apocrine
cells. Sometimes cytological atypia within cyst lining
epithelium may be detected, and this can be worrisome.
The frequency of carcinoma among all cystic lesions is
around 2% [2,3]. Complex cysts with thick walls or intra-
cystic masses may require further investigation because
their association with carcinoma is much stronger [4].
Solid lesions
In solid lesions the benefit of FNA is that it may offer a
prompt diagnosis. It is of paramount importance that the
results of FNA be interpreted as part of triple assess-
ment and not in isolation. This can avoid delays and over-
treatment.
In certain cases, such as fibroadenoma, FNA can provide
a specific histological diagnosis on the basis of benign
cytology [5]. Sometimes the subtype of carcinoma can be
identified on cytology. Other malignancies such as
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Abstract
In recent years we have seen significantly increased use of minimally invasive diagnostic techniques in
the management of breast disease. There is wide recognition of fine needle aspiration and core biopsy
as the principal diagnostic methods. However, concerns exist regarding their reliability. This article
provides a brief overview of the major diagnostic issues related to use of fine needle aspiration, core
biopsy and ductal lavage. It summarizes areas of use for each technique, outlines the main diagnostic
pitfalls and their causes, and provides a perspective on future developments in the field.
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lymphoma, melanoma or sarcoma have specific cytological
appearances.
Limitations of fine needle aspiration technique
The limitations of FNA can either be technical or related to
the nature of the lesion itself. Furthermore, there are limita-
tions that are specific to FNA regardless of technique or
lesion type (i.e. intrinsic limitations).
Technical limitations
False-negative diagnoses can result in diagnostic delay
and provide the patient with false reassurance. They may
result from incorrect localization, which can lead to non-
representative material. This can be overcome by using
imaging guidance. False-negative diagnoses may also
result from improper technique, which can yield inade-
quate or suboptimal material. Contamination with blood
can cause difficulties in interpretation. In addition, the
preparation of a thin, uniform smear is equally important
for accurate interpretation. It is very important that the
person conducting the FNA is well trained in the technique.
Sometimes, poor technique can mislead the unwary
pathologist into making a false-positive diagnosis. Exces-
sive application of force while spreading the smear can
lead to crushing and nuclear distortion and dissociation
(i.e. crushing artefacts), which can result in the false
impression of hyperchromasia. Also, delay in fixation of the
smear for Papanicolaou staining can result in cellular
enlargement; comparison with air-dried Giemsa stained
smears can be helpful in avoiding such false-positive diag-
noses. Finally, poor quality staining can cause artefactual
changes in the nature of the chromatin pattern.
Limitations related to the lesion itself
Apart from technical problems, sometimes the nature of
the lesion itself can cause diagnostic error. Some lesions
share similar features on FNA and are difficult to differenti-
ate from each other.
Certain types of lesions can lead to false-negative diag-
noses. For example, it is difficult to fix the small mobile
lesion by hand, and thus it may be missed. Also, it is diffi-
cult to aspirate fibrous lesions, and samples are often
hypocellular and haemorrhagic. The smears may show
only stromal fragments. Carcinomas can sometimes
induce dense fibrotic stroma, and in such cases a careful
search for malignant cells is necessary. In the case of
complex sclerosing lesions, the smears show small
uniform cells with mild or no atypia. The presence of bare
nuclei may be helpful in identifying the benign nature of
the lesion. However, the presence of concurrent in situ or
invasive carcinoma can be difficult to diagnose. In a pro-
portion of cases, further investigation with imaging modali-
ties and core biopsies may be necessary [6]. In the case
of necrotic and vascular lesions, the smears may not
contain any viable cells or may be haemorrhagic. Finally,
smears from lobular carcinoma can be hypocellular and
cells may not show significant pleomorphism. Their resem-
blance to lymphocytes may result in false-negative diagno-
sis. Cytology of tubular carcinoma can resemble many
benign conditions, including adenoma, microglandular
adenosis and fibroadenoma [7].
There are also types of lesions that can lead to false-positive
diagnoses. In epithelial hyperplasia it is sometimes difficult
to differentiate between usual type hyperplasia, hyperplasia
with atypia, and low-grade intraductal carcinoma. Three-
dimensional clusters of cells with atypia can cause diagnos-
tic problems. Also, with respect to fibroadenomas,
hyperplastic foci can mimic low-grade carcinoma. Similarly,
fibroadenomas with myxoid degeneration can be mistaken
for mucinous carcinoma [8]. Cytologically, epithelial cells
show mild nuclear pleomorphism with prominent nucleoli
during lactational changes, which can be a cause of false-
positive diagnosis. Finally, iatrogenic changes following pre-
vious FNA/biopsy can result in false-positive diagnoses.
Stromal cells of granulation tissue, inflammatory cells and
histiocytes can mimic carcinomas. Similarly, radiation-
induced atypia in benign epithelium can be worrisome.
Intrinsic limitations
There are a number of limitations that are intrinsic to FNA
cytology. First, identification of benign fibroadenoma or
frankly malignant phyllodes tumour may not be difficult, but
distinguishing between cellular fibroadenoma and a phyl-
lodes tumour can cause problems. Stromal cellularity and
the presence of a number of long spindle cells may be
helpful in some cases [9]. Second, the cytological appear-
ances of papillary lesions, which range from benign papil-
loma to invasive papillary carcinoma, can be similar. In
addition, benign papillomas can harbour areas of ductal
carcinoma in situ. All papillary lesions need complete exci-
sion, and in our opinion the cytopathologist should there-
fore not attempt to make a definitive diagnosis on the
basis of FNA findings, and often on the basis of a core
biopsy as well, unless frank carcinoma is present. Third, it
can sometimes be difficult to distinguish between a muco-
cele-like lesion and mucinous carcinoma on cytology. The
presence of high cellularity, single or small three-dimen-
sional groups of tumour cells, and cytological atypia
should raise suspicion of carcinoma [10]. Finally, in the
absence of architectural information, the distinction
between ductal carcinoma in situ (DCIS) and invasive car-
cinoma may be difficult cytologically [11].
Role of cytology in the evaluation of prognostic markers
Material obtained by aspiration techniques can be used to
evaluate the expression of receptors such as oestrogen
receptor and progesterone receptor, as well as the levels
of expression of other markers such as E cadherin and
p53. Cyto-centrifuged material is better with respect to307
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yield of tumour cells and in terms of antigen preservation
[12]. Encouraging results in evaluating the expression of
HER-2 by fluorescent in situ hybridization and immuno-
cytochemistry using aspiration material were recently
reported [13,14].
Needle core biopsy
The use of needle core biopsy has gained a wide accep-
tance, particularly with the advent of stereotactic guid-
ance. Use of smaller gauge needles has avoided the
complications of trauma, pain, use of anaesthetic agents
and tumour implantation in a biopsy tract. With needle
core samples, accurate subcategorization of carcinomas
as well as study of hormone receptors and other prognos-
tic markers is possible [15]. The false-positive rate with
needle biopsy is very low (0.2–0.3%); it is slightly higher
for nonpalpable lesions than for palpable ones [16].
However, some lesions can cause diagnostic problems,
and these are described below.
Fibroepithelial lesions
The distinction between fibroadenoma and phyllodes
tumour may be difficult on core biopsy. Stromal cellularity,
vesicular nuclei of stromal cells, mitotic figures and epithe-
lial hyperplasia should raise suspicion of the presence of
phyllodes tumour. In difficult cases excision biopsy is rec-
ommended [17].
Papillary lesions
Needle core biopsies of papillary lesions frequently show
the presence of loose papillary fragments. Occasionally,
architectural distortion caused by the needle can simulate
stromal invasion. Cytological atypia in a benign papilloma
is not uncommon. Similarly, benign papilloma can harbour
focal papillary carcinoma. In a recent study conducted by
Irfan and coworkers [18], 14.3% of the papillary lesions
diagnosed on stereo core biopsy demonstrated cancer on
subsequent excision. All of these problems cause great
difficulty in the diagnosis of papillary lesions, and therefore
papillary lesions should be completely excised, regardless
of cytological and architectural atypia.
Ductal carcinoma in situ and atypical ductal hyperplasia
Identification of high grade, commedo-type DCIS is not
difficult. However, bearing in mind the limited amount of
material obtained with needle core biopsy, the distinction
between low grade DCIS and atypical ductal hyperplasia
can be troublesome. Bonnett and coworkers [19] showed
that identification of severe atypical hyperplasia on core
biopsy was associated with a high probability of finding
DCIS on follow-up excision. Complete excision of these
lesions is recommended.
Invasive carcinoma
Use of immunohistochemical markers of myoepithelial
cells and basement membrane can be helpful in identifying
areas of tumour invasion. In our practice we found use
of immunostaining for S100 protein, smooth muscle
actin, calponin, cytokeratin 5/6 and cytokeratin 14 to be
simple and reliable. Identification of microinvasion is
possible on core biopsy but this does not provide assur-
ance that the material is representative of the entire
tumour.
Ductal lavage
Alongside FNA and core biopsy, a number of noninvasive
methods of sampling breast epithelium have recently
attracted increased interest both from researchers and
clinicians [20,21]. These methods include ductal lavage,
ductoscopy and examination of spontaneous nipple dis-
charge. The approach has some advantages; the nonin-
vasive nature of the procedure makes it attractive to
patients, medical practitioners and health service
providers. The technique of ductal lavage, with or without
ductoscopy, is less invasive than FNA and does not
involve needles; it is therefore better tolerated by nervous
patients. Technically, the method is not complicated and
the necessary experience could be acquired in a shorter
period of time than is required for other techniques. The
cost of the method is comparable to that for FNA, and
results are available quickly. In a recent study [22] it was
demonstrated that a large number of breast epithelial
cells can be collected by ductal lavage.
There are factors that limit the reliability of ductal lavage,
seriously restricting its use. The main obstacle is varied
cellularity of the sample and the degenerate nature of the
cells. Interestingly, even the origin of the cells in the
nipple lavage (histiocytic versus epithelial) was subject
to controversy. Thus far it has been demonstrated that
foam cells in the ductal lavage are undoubtedly of histio-
cytic origin, and a significant proportion of the cellular
population in the lavage consists of cells from the ductal
system [23].
The specificity of the ductal lavage method may vary
depending on the degree of cell degeneration because
degenerate cells can sometimes be mistaken for malignant
ones. Another important issue relates to the sensitivity of
the method (false-negative results may occur due to low
cell output). It has been suggested that lavage is potentially
a more sensitive method than nipple aspiration in detecting
cellular atypia [24]. The biotechnological revolution that
has occurred over recent years has given rise to attempts
to overcome the limitations of the noninvasive approach by
use of molecular biology methods. The potential utility of
DNA amplification, protein gel electrophoresis and mutage-
nesis assays was recently demonstrated. Amplification
techniques such as methylation-specific PCR may help to
increase the sensitivity of the method [25]. The use of non-
invasive methods is still very limited, but their role is likely to
increase in the future.308
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Conclusion
In summary, the use of minimally invasive and noninvasive
methods in cytological diagnosis of breast cancer repre-
sents an integral component of the triple approach and is
essential to the quality of the diagnostic process. An
understanding of the limitations of the methods, and of
their specificity and sensitivity is very important in optimiz-
ing their use in a multidisciplinary environment.
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